nach oben

Clinical Research in Cardiology

Erschienen in:

13.07.2018 | Review

From early beginnings to elaborate tools: contribution of German electrophysiology to the interventional treatment of cardiac arrhythmias

The German Cardiac Society welcomes ESC in Munich 2018

verfasst von: Thomas Fink, Michael Schlüter, Karl-Heinz Kuck

Erschienen in: Clinical Research in Cardiology | Sonderheft 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Catheter ablation evolved from the early days of cardiac electrophysiology (EP), in which invasive electrophysiological studies were mainly a tool to find the correct diagnosis and to evaluate the most effective anti-arrhythmic drug for the patient. Today, catheter ablation is the most effective treatment option for patients suffering from supraventricular and ventricular arrhythmias. The understanding of cardiac arrhythmias and treatment strategies improved because of physicians and scientists from all over the world. The work of German cardiologists led to new achievements in the field of cardiac EP and catheter ablation. In this article, we summarize selective contributions of German EP centres in the field.

Wellens HJJ (1971) Electrical stimulation of the heart in the study and treatment of tachycardias. Leiden, Stenfert Kroese

Vedel J, Frank R, Fontaine G et al (1978) Bloc auriculoventriculaire intra-hisien definitif induit au cours d’une exploration endoventriculaire droite. Arch Mal Coer 72:107–112

Scheinman MM, Morady F, Hess DS, Gonzalez R (1982) Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 248:851–855CrossRefPubMed

Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, Critelli G (1982) Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 306:194–200CrossRefPubMed

Borggrefe M, Budde T, Podczeck A, Breithardt G (1987) High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol 10:576–582CrossRefPubMed

Hindricks G, Haverkamp W, Gulker H, Rissel U, Budde T, Richter KD, Borggrefe M, Breithardt G (1989) Radiofrequency coagulation of ventricular myocardium: improved prediction of lesion size by monitoring catheter tip temperature. Eur Heart J 10:972–984CrossRefPubMed

Kuck KH, Jackman WM, Pitha J, Kunze KP, Carmen L, Schröder S, Nienaber CA (1988) Percutaneous catheter ablation at the mitral annulus in canines using a bipolar epicardial–endocardial electrode configuration. Pacing Clin Electrophysiol 11(6 Pt 1):760–775CrossRefPubMed

Jackman WM, Kuck KH, Naccarelli GV, Carmen L, Pitha J (1988) Radiofrequency current directed across the mitral anulus with a bipolar epicardial–endocardial catheter electrode configuration in dogs. Circulation 78(5 Pt 1):1288–1298CrossRefPubMed

Kuck KH, Schlüter M, Geiger M, Siebels J, Duckeck W (1991) Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 337:1557–1561CrossRefPubMed

10.

Jackman WM, Wang XZ, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI et al (1991) Catheter ablation of accessory atrioventricular pathways (Wolff–Parkinson–White syndrome) by radiofrequency current. N Engl J Med 324:1605–1611CrossRefPubMed

11.

Kuck KH, Schlüter M (1991) Single-catheter approach to radiofrequency current ablation of left-sided accessory pathways in patients with Wolff–Parkinson–White syndrome. Circulation 84:2366–2375CrossRefPubMed

12.

Schlüter M, Kuck KH (1992) Catheter ablation from right atrium of anteroseptal accessory pathways using radiofrequency current. J Am Coll Cardiol 19:663–670CrossRefPubMed

13.

Deisenhofer I, Zrenner B, Yin YH, Pitschner HF, Kuniss M, Grossmann G, Stiller S, Luik A, Veltmann C, Frank J, Linner J, Estner HL, Pflaumer A, Wu J, von Bary C, Ucer E, Reents T, Tzeis S, Fichtner S, Kathan S, Karch MR, Jilek C, Ammar S, Kolb C, Liu ZC, Haller B, Schmitt C, Hessling G (2010) Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicentre prospective randomized trial. Circulation 122:2239–2245CrossRefPubMed

14.

Ernst S, Schlüter M, Ouyang F, Khanedani A, Cappato R, Hebe J, Volkmer M, Antz M, Kuck KH (1999) Modification of the substrate for maintenance of idiopathic human atrial fibrillation: efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 100:2085–2092CrossRefPubMed

15.

Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666CrossRefPubMed

16.

Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, Barthel P, Luciani E, Schömig A, Schmitt C (2005) Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111:2875–2880CrossRefPubMed

17.

Arentz T, Weber R, Bürkle G, Herrera C, Blum T, Stockinger J, Minners J, Neumann FJ, Kalusche D (2007) Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation 115:3057–3063CrossRefPubMed

18.

Ouyang F, Bänsch D, Ernst S, Schaumann A, Hachiya H, Chen M, Chun J, Falk P, Khanedani A, Antz M, Kuck KH (2004) Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 110:2090–2096CrossRefPubMed

19.

Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT, Schaumann A, Chun J, Falk P, Hennig D, Liu X, Bänsch D, Kuck KH (2005) Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 111:127–135CrossRefPubMed

20.

Kuck KH, Hoffmann BA, Ernst S, Wegscheider K, Treszl A, Metzner A, Eckardt L, Lewalter T, Breithardt G, Willems S (2016) Gap-AF–AFNET 1 Investigators. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-german atrial fibrillation competence network 1 trial. Circ Arrhythm Electrophysiol 9:e003337CrossRefPubMed

21.

Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, Neven K, Köktürk B, Konstantinidou M, Metzner A, Fuernkranz A, Kuck KH (2010) Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 122:2368–2377CrossRefPubMed

22.

Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, Mathew S, Yoshiga Y, Wissner E, Kuck KH, Ouyang F (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60:1921–1929CrossRefPubMed

23.

Tilz RR, Heeger CH, Wick A, Saguner AM, Metzner A, Rillig A, Wohlmuth P, Reissmann B, Lemeš C, Maurer T, Santoro F, Riedl J, Sohns C, Mathew S, Kuck KH, Ouyang F (2018) Ten-year clinical outcome after circumferential pulmonary vein isolation utilizing the Hamburg approach in patients with symptomatic drug-refractory paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 11:e005250CrossRefPubMed

24.

Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D, CASTLE-AF Investigators (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378:417–427CrossRefPubMed

25.

Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, Kurzidim K, Berkowitsch A, Koller M, Heintze J, Scholz U, Wetzel U, Schneider MA, Horstkotte D, Hamm CW, Pitschner HF (2008) Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-centre study. J Am Coll Cardiol 52:273–278CrossRefPubMed

26.

Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nölker G (2013) Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol 61:1707–1712CrossRefPubMed

27.

Luik A, Radzewitz A, Kieser M, Walter M, Bramlage P, Hörmann P, Schmidt K, Horn N, Brinkmeier-Theofanopoulou M, Kunzmann K, Riexinger T, Schymik G, Merkel M, Schmitt C (2015) Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority FreezeAF study. Circulation 132:1311–1319CrossRefPubMedPubMedCentral

28.

Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245CrossRefPubMed

29.

Chun KR, Stich M, Fürnkranz A, Bordignon S, Perrotta L, Dugo D, Bologna F, Schmidt B (2017) Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial. Heart Rhythm 14:495–500CrossRefPubMed

30.

Wissner E, Heeger CH, Grahn H, Reissmann B, Wohlmuth P, Lemes C, Rausch P, Mathew S, Rillig A, Deiss S, Maurer T, Lin T, Tilz RR, Ouyang F, Kuck KH, Metzner A (2015) One-year clinical success of a ‘no-bonus’ freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation. Europace 17:1236–1240CrossRefPubMed

31.

Reissmann B, Wissner E, Deiss S, Heeger C, Schlueter M, Wohlmuth P, Lemes C, Mathew S, Maurer T, Sohns C, Saguner A, Santoro F, Hayashi K, Riedl J, Ouyang F, Kuck KH, Metzner A (2017) First insights into cryoballoon-based pulmonary vein isolation taking the individual time-to-isolation into account. Europace 19:1676–1680CrossRefPubMed

32.

Schmidt B, Neuzil P, Luik A, Osca Asensi J, Schrickel JW, Deneke T, Bordignon S, Petru J, Merkel M, Sediva L, Klostermann A, Perrotta L, Cano O, Chun KRJ (2017) Laser balloon or wide-area circumferential irrigated radiofrequency ablation for persistent atrial fibrillation: a multicentre prospective randomized study. Circ Arrhythm Electrophysiol 10:e005767CrossRefPubMed

33.

Kuck KH, Reddy VY, Schmidt B, Natale A, Neuzil P, Saoudi N, Kautzner J, Herrera C, Hindricks G, Jaïs P, Nakagawa H, Lambert H, Shah DC (2012) A novel radiofrequency ablation catheter using contact force sensing: TOCCATA study. Heart Rhythm 9:18–23CrossRefPubMed

34.

Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, Lambert H, Yulzari A, Wissner E, Kuck KH (2013) Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol 6:327–333CrossRefPubMed

35.

Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH (2015) EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 17:1229–1235CrossRefPubMedPubMedCentral

36.

Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C, Jaïs P, Hindricks G, Peichl P, Yulzari A, Lambert H, Neuzil P, Natale A, Kuck KH (2012) The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 9:1789–1795CrossRefPubMed

37.

Ernst S, Ouyang F, Linder C, Hertting K, Stahl F, Chun J, Hachiya H, Bänsch D, Antz M, Kuck KH (2004) Initial experience with remote catheter ablation using a novel magnetic navigation system: magnetic remote catheter ablation. Circulation 109:1472–1475CrossRefPubMed

38.

Chun JK, Ernst S, Matthews S, Schmidt B, Bansch D, Boczor S, Ujeyl A, Antz M, Ouyang F, Kuck KH (2007) Remote-controlled catheter ablation of accessory pathways: results from the magnetic laboratory. Eur Heart J 28:190–195CrossRefPubMed

39.

Arya A, Kottkamp H, Piorkowski C, Bollmann A, Gerdes-Li JH, Riahi S, Esato M, Hindricks G (2008) Initial clinical experience with a remote magnetic catheter navigation system for ablation of cavotricuspid isthmus-dependent right atrial flutter. Pacing Clin Electrophysiol 31:597–603CrossRefPubMed

40.

Rillig A, Schmidt B, Di Biase L, Lin T, Scholz L, Heeger CH, Metzner A, Steven D, Wohlmuth P, Willems S, Trivedi C, Galllinghouse JG, Natale A, Ouyang F, Kuck KH, Tilz RR (2017) Manual versus robotic catheter ablation for the treatment of atrial fibrillation: the Man and Machine trial. JACC Clin Electrophysiol 3:875–883CrossRefPubMed

41.

Sommer P, Grothoff M, Eitel C, Gaspar T, Piorkowski C, Gutberlet M, Hindricks G (2013) Feasibility of real-time magnetic resonance imaging-guided electrophysiology studies in humans. Europace 15:101–108CrossRefPubMed

42.

Piorkowski C, Grothoff M, Gaspar T, Eitel C, Sommer P, Huo Y, John S, Gutberlet M, Hindricks G (2013) Cavotricuspid isthmus ablation guided by real-time magnetic resonance imaging. Circ Arrhythm Electrophysiol 6:e7–e10CrossRefPubMed

43.

Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS, VTACH study Group (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375:31–40CrossRefPubMed

44.

Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, Zarse M, Hohnloser SH, Kautzner J, Willems S; SMS Investigators (2017) Impact of substrate modification by catheter ablation on implantable cardioverter–defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol 10:e004422CrossRefPubMed

45.

Kottkamp H, Hindricks G, Chen X, Brunn J, Willems S, Haverkamp W, Block M, Breithardt G, Borggrefe M (1995) Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy. Circulation 92:1159–1168CrossRefPubMed

46.

Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C, Hindricks G, Arya A (2014) Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation 129:728–736CrossRefPubMed

47.

Ouyang F, Cappato R, Ernst S, Goya M, Volkmer M, Hebe J, Antz M, Vogtmann T, Schaumann A, Fotuhi P, Hoffmann-Riem M, Kuck KH (2002) Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the purkinje network. Circulation 105:462–469CrossRefPubMed

48.

Ouyang F, Fotuhi P, Ho SY, Hebe J, Volkmer M, Goya M, Burns M, Antz M, Ernst S, Cappato R, Kuck KH (2002) Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol 39:500–508CrossRefPubMed

49.

Ouyang F, Mathew S, Wu S, Kamioka M, Metzner A, Xue Y, Ju W, Yang B, Zhan X, Rillig A, Lin T, Rausch P, Deiß S, Lemes C, Tönnis T, Wissner E, Tilz RR, Kuck KH, Chen M (2014) Ventricular arrhythmias arising from the left ventricular outflow tract below the aortic sinus cusps: mapping and catheter ablation via transseptal approach and electrocardiographic characteristics. Circ Arrhythm Electrophysiol 7:445–455CrossRefPubMed

50.

Siebels J, Cappato R, Rüppel R, Schneider MA, Kuck KH (1993) Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. Am J Cardiol 72:109F–113FCrossRefPubMed

51.

Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583CrossRef

52.

Kuck KH, Cappato R, Siebels J, Rüppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748–754CrossRefPubMed

53.

Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21:2071–2078CrossRefPubMed

54.

Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the cardiomyopathy trial (CAT). Circulation 105:1453–1458CrossRefPubMed

55.

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med 352:225–237CrossRefPubMed

56.

Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158CrossRefPubMed

57.

Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221–1230CrossRefPubMed

Titel: From early beginnings to elaborate tools: contribution of German electrophysiology to the interventional treatment of cardiac arrhythmias
The German Cardiac Society welcomes ESC in Munich 2018
verfasst von: Thomas Fink
Michael Schlüter
Karl-Heinz Kuck
Publikationsdatum: 13.07.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe Sonderheft 2/2018
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1319-y

Neu im Fachgebiet Kardiologie

19.04.2024 | Vorhofflimmern | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

From early beginnings to elaborate tools: contribution of German electrophysiology to the interventional treatment of cardiac arrhythmias

The German Cardiac Society welcomes ESC in Munich 2018

Abstract

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2018

Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University

Therapeutic options in advanced heart failure

German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock

Biomarker in cardiology

Percutaneous coronary intervention: balloons, stents and scaffolds

Progress in heart failure treatment in Germany

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie